Twist Bioscience Corporation Common Stock (TWST) Financials
Key financial figures for Twist Bioscience Corporation Common Stock (Q3 2026).
- Revenue
- $118M
- Net Income
- -$35M
- EPS
- $-0.56
- Total Assets
- $672M
- Operating Cash Flow
- $1M
Full income statement, balance sheet, and cash flow for Twist Bioscience Corporation Common Stock on SentiSense.